Israel will begin human trials for a potential COVID-19 vaccine developed by a research institute overseen by the Defence Ministry on Nov. 1 after receiving regulatory approval, the ministry said on Sunday.
FILE PHOTO: Men wearing protective face masks chat on a bench near shuttered shops amid Israel’s second national coronavirus disease (COVID-19) lockdown in Ashkelon, Israel October 7, 2020.REUTERS/Amir Cohen
JERUSALEM (Reuters) –
The Israel Institute for Biological Research (IIBR) began animal trials for its “BriLife” vaccine in March. The Health Ministry and an oversight committee have now given the green light to take it to the next stage.
Eighty volunteers aged between 18 and 55 will be monitored for three weeks to see if virus…
Read full article